SecBot SecBot
8-K ·Filed Mar 5, 2026

CYH

COMMUNITY HEALTH SYSTEMS INC
NEUTRAL
Impact 5/10
Horizonweeks Processed8mo ago SEC0001193125-26-094191
8-K material event: Items 1.01
Actionable Insight • Neutral

Monitor for closing in Q2 2026 and watch for CYH's announcement of how proceeds will be deployed, which could provide insight into future capital allocation strategy. The transaction represents a modest portfolio rationalization rather than a transformative event.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$3.35
T+0 close · Mar 5, 2026 · via day close
Latest settled
−17.91%
T+60 · $2.75
Vs SPY
−30.69%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 6 $3.35entry
  2. T+1 · 8mo ago +4.78%α +3.93% · $3.51
  3. T+5 · 8mo ago −4.48%α −2.95% · $3.20
  4. T+20 · 8mo ago −11.34%α −9.30% · $2.97
  5. T+60 · 6mo ago −17.91%α −30.69% · $2.75
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Community Health Systems (CYH) has agreed to sell four Arkansas hospitals and related assets to Freeman Health System for $112 million, plus net working capital adjustments. The transaction, expected to close in Q2 2026, is part of CYH's portfolio optimization strategy and represents a divestiture of non-core assets.

Key Financial Metrics

Deal Value
$112.0M
Deal Type
acquisition

Key Facts

  • Community Health Systems (CYH) is selling four Arkansas hospitals to Freeman Health System
  • Total purchase price is $112 million, subject to net working capital and lease adjustments
  • The transaction includes Northwest Medical Center - Bentonville, Northwest Medical Center - Springdale, Northwest Medical Center - Willow Creek Women's Hospital, and Siloam Springs Regional Hospital
  • Closing expected in second quarter of 2026, subject to regulatory approvals
  • Freeman Health System is a Missouri-based nonprofit health system
  • The divestiture is part of CYH's previously announced portfolio optimization strategy

Financial Impact

Approximately $112 million in proceeds, plus net working capital adjustments

revenueasset baseoperating income

Risk Factors

  • Closing could be delayed or fail to occur due to regulatory approvals or other closing conditions
  • Potential disruption to operations during transition period
  • Impact on CYH's revenue base from divesting four facilities

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-094191
Document: cyh-20260305.htm0001193125-26-094191
Document: cyh-ex99_1.htm0001193125-26-094191
Document: 0001193125-26-094191-index-headers.html0001193125-26-094191
Document: 0001193125-26-094191-index.html0001193125-26-094191
Document: 0001193125-26-094191.txt0001193125-26-094191

Track record

5 reports on CYH

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $2.17 Now $2.13 −1.84% settles Nov 17
  2. Oct 28, 202619d ago 8-K Bearish 6/10 Entry $2.41 to $2.28 Now $2.13 +11.62% ▲ +5.39% +0.67% vs SPY
  3. Jun 1, 202624w ago 8-K Neutral 5/10 Entry $2.78 to $2.87 Now $2.13 −23.38% ▲ +3.24% +6.20% vs SPY
  4. Apr 21, 202629w ago 8-K Bearish 7/10 Entry $2.71 to $2.87 Now $2.13 +21.40% ▼ −5.90% −5.85% vs SPY
  5. Mar 5, 202636w ago 8-K Neutral 5/10 Viewing Entry $3.35 to $3.20 Now $2.13 −36.42% ▼ −4.48% −2.95% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens in 7h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026